Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C6VV
|
|||
| Former ID |
DCL001125
|
|||
| Drug Name |
Prolarix
|
|||
| Synonyms |
Prolarix (TN)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 2 | [1] | |
| Therapeutic Class |
Anticancer Agents
|
|||
| Company |
Protherics
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H11N3O2
|
|||
| Canonical SMILES |
C1C=CN(C=C1C(=O)N)CC(=O)N
|
|||
| InChI |
1S/C8H11N3O2/c9-7(12)5-11-3-1-2-6(4-11)8(10)13/h1,3-4H,2,5H2,(H2,9,12)(H2,10,13)
|
|||
| InChIKey |
WEJRSYKFMCUCRQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 64881-21-6
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Quinone reductase 2 (NQO2) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00746590) Study of Anti-tumour Effects and Safety of Prolarix in Hepatocellular Carcinoma. U.S. National Institutes of Health. | |||
| REF 2 | CenterWatch. Drugs in Clinical Trials Database. CenterWatch. 2008. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.